Notice of Effectiveness

Spyre Therapeutics, Inc. Filed 2023-11-20 Acc 9999999995-23-003387

Documents 1

2024-04-01 EFFECT Notice of Effectiveness
2023-11-24 8-K Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
2023-11-20 EFFECT Notice of Effectiveness
2023-11-17 CORRESP Correspondence Between Filers and SEC Staff
2023-11-15 CORRESP Correspondence Between Filers and SEC Staff
2023-11-15 S-1/A Registration Statement
2021-06-08 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…